Sector
PharmaceuticalsOpen
₹62Prev. Close
₹56.4Turnover(Lac.)
₹2.7Day's High
₹62Day's Low
₹56.1152 Week's High
₹114.952 Week's Low
₹47.26Book Value
₹22.24Face Value
₹10Mkt Cap (₹ Cr.)
44.34P/E
21.76EPS
2.59Divi. Yield
09 Sep 2024
12:00 AM
AGM
Announcement Date: 09 Sep, 2024
18 Jun 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 7.87 | 7.87 | 7.87 | 7.87 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 7.61 | 6.08 | 4.72 | 3.7 |
Net Worth | 15.48 | 13.95 | 12.59 | 11.57 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 26.58 | 27.64 | 18.93 | 29.96 |
yoy growth (%) | -3.85 | 45.99 | -36.81 | -2.06 |
Raw materials | -17.35 | -17.59 | -15.54 | -18.64 |
As % of sales | 65.28 | 63.63 | 82.11 | 62.22 |
Employee costs | -3.76 | -2.36 | -2.14 | -2.29 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.93 | 0.8 | 0.44 | 0.42 |
Depreciation | -0.81 | -0.76 | -0.52 | -0.51 |
Tax paid | -0.21 | -0.42 | 0.09 | -0.23 |
Working capital | 0.77 | -2.84 | 3.28 | 4.31 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -3.85 | 45.99 | -36.81 | -2.06 |
Op profit growth | -61.52 | -167.92 | -217.49 | -358.67 |
EBIT growth | -6.08 | 41.31 | -23.07 | 12.72 |
Net profit growth | 92.51 | -31.03 | 187.01 | 9.61 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
T G Raghavendra
Whole-time Director
V J Sarma
Non-Exec. & Independent Dir.
O Mohan Rao
Non-Exec. & Independent Dir.
A Satyanarayana Murthy
Non-Exec. & Independent Dir.
Karunasree
Company Sec. & Compli. Officer
I V Lakshmi
17/745 Alur Road,
Kurnool District,
Andhra Pradesh - 518301
Tel: -
Website: http://www.roopaindustries.com
Email: investors.roopa@gmail.com; info@roopaindustries.co
1-2-285 Domalguda,
Hyderabad - 500 029
Tel: 91-040-27638111/4445
Website: www.aarthiconsultants.com
Email: info@aarthiconsultants.com
Summary
Roopa Industries Limited is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Che...
Read More
Reports by Roopa Industries Ltd
What is the Roopa Industries Ltd share price today?
What is the Market Cap of Roopa Industries Ltd?
What is the PE and PB ratio of Roopa Industries Ltd?
What is the 52 Week High and Low of Roopa Industries Ltd?
What is the CAGR of Roopa Industries Ltd?
What is the shareholding pattern of Roopa Industries Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.